Minerva Neurosciences, Inc. Warrants Not Settleable in Cash, Fair Value Disclosure
Minerva Neurosciences, Inc. (NERV) had Warrants Not Settleable in Cash, Fair Value Disclosure of $200.00 thousand as of 2016-01-15, per its 10-Q filed 2023-08-01.
Discontinued › Notes › Fair Value Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2023-08-01
- 2016-01-15: Warrants Not Settleable in Cash, Fair Value Disclosure $200.00K.
- 2015-01-16: Warrants Not Settleable in Cash, Fair Value Disclosure $200.00K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2016-01-15 | $200.00K 10-Q · filed 2023-08-01 |
| 2015-01-16 | $200.00K 10-Q · filed 2020-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |